June 03, 2018
New system would mean less than a third of women with most common type would need chemo
Thousands of breast cancer patients could avoid chemo, study finds
Thousands of women with the most common form of early breast cancer may be spared chemotherapy under a new “precision medicine” approach, according to a landmark study.
Researchers estimate more than 123,000 women in the US and 23,000 women in the UK are diagnosed with the particular form of the disease each year. If the findings are implemented, less than a third of them would need chemotherapy, rather than half.
“Practically speaking, this means that thousands of women will be able to avoid chemotherapy, with all of its side effects, while still achieving excellent long-term outcomes,” said Dr Harold Burstein, an associate professor at Harvard Medical School.
Breast cancer is the most common cancer in women worldwide. This study looked at women with early hormone-receptor-positive, HER2-negative, axillary-node-negative breast cancer, which accounts for about half of all cases.
For most women, standard care involves chemotherapy and endocrine therapy, in part because of chemotherapy’s proportionally greater benefits for young women.
Chemotherapy is often accompanied by nausea, vomiting, hair loss and fatigue in the short-term, and in rare cases by leukaemia. Researchers were able to separate, through genetic testing, women more likely to have recurrent cancer, which could potentially spare thousands from the treatment.
The study, Trial Assigning Individualised Options for Treatment (Tailorx) was presented as a plenary session at the annual meeting of the American Society of Clinical Oncology in Chicago.
“By stratifying these breast cancer patients and finding that only those with the highest risk of recurrence need to have chemotherapy based on their tumour genetics, Tailorx shows great potential to ensure more gentle treatment without compromising its effectiveness,” said Prof Arnie Purushotham, a senior clinical adviser at Cancer Research UK.
Researchers looked at more than 10,000 women aged 18 to 75. Each had oncotype DX, a type of biopsy that looks at 21 tumour genes. The test assigned women a score from 0 to 100 based on the likelihood cancer would return within 10 years.
Researchers already knew women with scores of 0-10 did not benefit from chemotherapy – about 17% of the women in the study. Conversely, women with a risk score of 26 or more (14% of the study) did benefit from chemotherapy. The study’s aim was to assess the majority of women in the middle, with a score of 11-25.
Of the 10,273 women tested, 6,711 (69%) had a score of 11-25. They were randomly assigned to receive endocrine therapy alone, or a combination of endocrine and chemotherapy. Researchers concluded that, depending on a patient’s age, women who received only endocrine therapy did not fare worse than those who were also treated with chemotherapy.
It means women over 50 with this type of cancer and a score of 0-25 do not need chemotherapy. Women younger than 50 with a score of 0-15 can also avoid the difficult treatment.
The authors said it was the largest precision medicine trial ever done. “It’s fantastic news that this landmark study could now enable thousands more breast cancer patients over 50 to be safely spared gruelling chemotherapy,” said Delyth Morgan, the chief executive at Breast Cancer Now.
“This is another significant step towards personalised breast cancer treatment and we hope these practice-changing findings will now help refine our use of chemotherapy on the NHS.”
“Half of all breast cancers are hormone receptor-positive, HER2-negative, and axillary node-negative,” said the lead author, Dr Joseph Sparano, an associate director of clinical research at Albert Einstein Cancer Center and Montefiore Health System in New York, and vice-chair of the Eastern Cooperative Oncology Group.
“Our study shows that chemotherapy may be avoided in about 70% of these women when its use is guided by the test, thus limiting chemotherapy to the 30% who we can predict will benefit from it.”
Providing chemotherapy costs the NHS about £4,500 for each patient. In the US, chemotherapy can cost more than $140,000 (£105,000). The list price of oncotype DX is £2,580; however, the NHS gets a subsidised rate. Most American insurance companies cover the cost of the test.
Latest News
Top news around the world
Academy Awards

‘Oppenheimer’ Reigns at Oscars With Seven Wins, Including Best Picture and Director

Get the latest news about the 2024 Oscars, including nominations, winners, predictions and red carpet fashion at 96th Academy Awards

Around the World

Celebrity News

> Latest News in Media

Watch It
Olivia Munn Reveals Breast Cancer Diagnosis and Double Mastectomy Procedure | E! News
March 13, 2024
kUaEV1Kd3S0
Travis Kelce Shares Details From His Trip to Singapore With Taylor Swift | E! News
March 13, 2024
3YXi-Dgf4eg
Kate Middleton VIRAL Photo: Agency Addresses Photoshop Claims | E! News
March 13, 2024
S4VkO0TpkCY
Da'Vine Joy Randolph Plays 'Smash or Pass' With Iconic Moments From Her Career
March 13, 2024
vkPdJEF2BX4
Jean Smart Wears a Hotel Bathrobe to Present an Award to Hannah Einbinder l Power of Comedy SxSW
March 12, 2024
Bw7uVEYQev4
Lenny Kravitz Walk of Fame Ceremony
March 12, 2024
MlWq8BcnwhE
Dak Prescott Extortion Plot & Steph Curry for President? | TMZ Sports Full Ep - 3/12/24
March 13, 2024
jHFsrjs7OFY
A Japanese space rocket blew up after takeoff Tuesday, turning the sky into a fireball of smoke.
March 13, 2024
YkfJ3Qg8B7c
#KimKardashian and #BiancaCensori hung out at #KanyeWest's listening party Tuesday night!
March 13, 2024
EfwLLq6bx9k
‘Pioneer Woman’ Ree Drummond denies using Ozempic to lose 60 pounds
March 13, 2024
Omfjk1AlZ3A
Chrissy Teigen reveals her ‘boob lift scars’ in daring dress at Jay-Z & Beyoncé’s Oscars 2024 party
March 13, 2024
VxZ2qXAlpmU
Zoë Kravitz pokes fun at dad Lenny Kravitz's style during Hollywood Walk of Fame speech
March 13, 2024
j3-lcFu_1sQ
TV Schedule
Late Night Show
Watch the latest shows of U.S. top comedians

Sports

Latest sport results, news, videos, interviews and comments
Latest Events
17
Mar
SPAIN: La Liga
Atletico Madrid - Barcelona
17
Mar
ENGLAND: FA Cup
Manchester United - Liverpool
17
Mar
ITALY: Serie A
Inter Milan - Napoli
17
Mar
GERMANY: Bundesliga
Borussia Dortmund - Eintracht Frankfurt
17
Mar
ENGLAND: FA Cup
Chelsea - Leicester City
17
Mar
ITALY: Serie A
Roma - Sassuolo
17
Mar
ITALY: Serie A
Verona - AC Milan
17
Mar
ITALY: Serie A
Juventus - Genoa
17
Mar
GERMANY: Bundesliga
SC Freiburg - Bayer Leverkusen
17
Mar
USA: Major League Soccer
Atlanta United - Orlando City
17
Mar
ENGLAND: Premier League
West Ham United - Aston Villa
17
Mar
SPAIN: La Liga
Rayo Vallecano - Real Betis
17
Mar
ENGLAND: Championship
Leeds - Millwall
17
Mar
SPAIN: La Liga
Las Palmas - Almeria
17
Mar
SPAIN: La Liga
Villarreal - Valencia
17
Mar
SPAIN: La Liga
Sevilla - Celta Vigo
16
Mar
GERMANY: Bundesliga
Darmstadt - Bayern Munich
16
Mar
ENGLAND: FA Cup
Manchester City - Newcastle United
16
Mar
ENGLAND: Premier League
Fulham - Tottenham Hotspur
16
Mar
SPAIN: La Liga
Osasuna - Real Madrid
13
Mar
CHAMPIONS LEAGUE: 1/8 Final
Atletico Madrid - Inter Milan
12
Mar
CHAMPIONS LEAGUE: 1/8 Final
Barcelona - Napoli
12
Mar
CHAMPIONS LEAGUE: 1/8 Final
Arsenal - Porto
11
Mar
ENGLAND: Premier League
Chelsea - Newcastle United
10
Mar
ENGLAND: Premier League
Liverpool - Manchester City
10
Mar
SPAIN: La Liga
Real Madrid - Celta Vigo
10
Mar
ENGLAND: Premier League
Aston Villa - Tottenham Hotspur
10
Mar
ITALY: Serie A
Juventus - Atalanta
10
Mar
ITALY: Serie A
Fiorentina - Roma
10
Mar
ITALY: Serie A
AC Milan - Empoli
09
Mar
GERMANY: Bundesliga
Werder Bremen - Borussia Dortmund
09
Mar
ENGLAND: Premier League
Arsenal - Brentford
09
Mar
ITALY: Serie A
Bologna - Inter Milan
Find us on Instagram
at @feedimo to stay up to date with the latest.
Featured Video You Might Like
zWJ3MxW_HWA L1eLanNeZKg i1XRgbyUtOo -g9Qziqbif8 0vmRhiLHE2U JFCZUoa6MYE UfN5PCF5EUo 2PV55f3-UAg W3y9zuI_F64 -7qCxIccihU pQ9gcOoH9R8 g5MRDEXRk4k
Copyright © 2020 Feedimo. All Rights Reserved.